Shandong Keyuan Pharmaceutical Co., Ltd. (SHE:301281)

China flag China · Delayed Price · Currency is CNY
41.94
-1.84 (-4.20%)
At close: Mar 9, 2026
26.44%
Market Cap 4.54B
Revenue (ttm) 435.52M
Net Income (ttm) 52.06M
Shares Out 108.29M
EPS (ttm) 0.48
PE Ratio 86.72
Forward PE n/a
Dividend 0.20 (0.46%)
Ex-Dividend Date May 20, 2025
Volume 3,354,372
Average Volume 5,735,720
Open 43.00
Previous Close 43.78
Day's Range 41.60 - 43.59
52-Week Range 24.60 - 46.80
Beta -0.95
RSI 61.59
Earnings Date Apr 16, 2026

About SHE:301281

Shandong Keyuan Pharmaceutical Co., Ltd. is involved in the research and development, manufacture, and marketing of chemical raw materials and their preparations. It offers gliclazide; metformin hydrochloride; isosorbide mononitrate; isosorbide dinitrate; lansoprazole; mecobalamin; ropivacaine hydrochloride; isoflurane; fluoxetine hydrochloride; clemastine fumarate; chlorpheniramine maleate; esmolol hydrochloride; nicotinamide-tinidazole; amlexanox; nisoldipine; qupibutu; clarithromycin lactobionate; propafenone hydrochloride; potassium diclofe... [Read more]

Sector Healthcare
Founded 2004
Employees 696
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 301281
Full Company Profile

Financial Performance

In 2024, SHE:301281's revenue was 463.72 million, an increase of 3.60% compared to the previous year's 447.58 million. Earnings were 60.27 million, a decrease of -21.76%.

Financial Statements

News

There is no news available yet.